Riskpilot← Back to searchSign inGet full accessMeliva Vårdcentral Bagarmossen AB
ABActiveOrg 5566144191Lillåvägen 68General medical practice activities · NACE 8621Est. 200120-49 employees
Revenue 2024
SEK 50,9M
+4% vs 2023
EBITDA margin
1.5%
+167% vs 2023
Equity ratio
67.5%
Financial strength
Net profit 2024
SEK 568K
+492% vs 2023
| Revenue | SEK 50,9M | +4% |
| EBITDA | SEK 740K | +167% |
| Net profit | SEK 568K | +492% |
| Total assets | SEK 16,1M | +4% |
| Equity | SEK 10,9M | +3% |
| Employees | — | — |
Legal name
Meliva Vårdcentral Bagarmossen AB
Org number
5566144191
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
13 augusti 2001
Share capital
SEK 200 000
Employees
20-49
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas var för sig av Schmidt, Matti Artturi Soininen, Herkko Sampa Westerholm, Anders Peter Mikael
Company purpose
Bolaget skall bedriva öppenvårdsmottagning, hemsjukvård, läkarinsatser i särskilt boende samt därmed förenlig verksamhet.
Address
Lillåvägen 68
Phone
+4686865350
Email
maj-len.eklund@dvcb.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 45 448 | 46 944 | 47 256 | 49 089 | 50 941 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 905 | 1 747 | 811 | −1 104 | 740 |
| Depreciation & amort. | −59 | −88 | −138 | −117 | −111 |
| EBIT | 846 | 1 659 | 673 | −1 221 | 629 |
| Net financials | 12 | 9 | 24 | 270 | 268 |
| Profit before tax | 636 | 1 255 | 527 | −145 | 696 |
| Tax | −143 | −264 | −120 | −0 | −128 |
| Net profit | 493 | 991 | 407 | −145 | 568 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 15 780 | 17 300 | 16 330 | 15 511 | 16 080 |
| Equity | 9 989 | 10 629 | 10 837 | 10 512 | 10 861 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 5 569 | 6 035 | 4 687 | 5 000 | 5 018 |
| Total debt | 5 569 | 6 035 | 4 687 | 5 000 | 5 018 |
EBITDA margin
1.5%
This company
15.8%
Market median
-91% vs market
20202024
Equity ratio
67.5%
This company
38.2%
Market median
+77% vs market
20202024
Return on equity
5.2%
This company
18.4%
Market median
-72% vs market
20202024
Net profit margin
1.1%
This company
8.1%
Market median
-86% vs market
20202024
Asset turnover
3.17×
This company
1.12×
Market median
+183% vs market
20202024
Debt / equity
0.48×
This company
0.62×
Market median
+23% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
JJ Chief Auditor | Chief Auditor | 2025 |
MA External Signatory | External Signatory | 2025 |
AP Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (4) | ||
BI Auditor Substitute | Auditor Substitute | 2020 – 2025 |
HP Audit | Audit | 2020 – 2022 |
| Audit | 2021 – 2025 | |
NE Chief Executive Officer | Chief Executive Officer | 2020 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2025 | |
| Chairman | 2025 | |
| Board of Directors | 2025 | |
| Former (12) | ||
| Deputy Board Member | 2025 – 2025 | |
| Board of Directors | 2024 – 2025 | |
| Board of Directors | 2021 – 2025 | |
| Board of Directors | 2020 – 2021 | |
| Deputy Board Member | 2020 – 2020 | |
| Board of Directors | 2021 – 2025 | |
| Deputy Board Member | 2022 – 2024 | |
| Chairman | 2020 – 2025 | |
| Board of Directors | 2020 – 2025 | |
| Board of Directors | 2020 – 2025 | |
| Board of Directors | 2020 – 2025 | |
| Deputy Board Member | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2026 | |
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MEHILÄINEN OY
Meliva Vårdcentral Bagarmossen AB Board members of Meliva Vårdcentral Bagarmossen AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bengt Ivar Beergrehn | Auditor Substitute | 0 companies |
| John Joakim Holmquist | Chief Auditor | 0 companies |
| Hans Peter Olofson | Audit | 0 companies |
| Marcus Hans Eric Jönsson Vallas | Audit | 0 companies |
| Matti Artturi Schmidt | External Signatory | 0 companies |
| Anders Peter Mikael Westerholm | Chief Executive Officer | 0 companies |
| Niran El Kouni | Chief Executive Officer | 0 companies |
| Karin Ragnhild Elisabeth Risberg | Deputy Board Member | 0 companies |
| Birgitta Daniella Gräske | Board of Directors | 0 companies |
| Sami Jukka Petteri Koski | Board of Directors | 0 companies |
| Gun Marguerite Engström | Board of Directors | 0 companies |
| Per Åke Mattsson | Board of Directors | 0 companies |
| Jan Peter Randmaa | Deputy Board Member | 0 companies |
| Sara Johanna Kullander | Board of Directors | 0 companies |
| Jenny Maria Eriksson | Deputy Board Member | 0 companies |
| Herkko Sampa Soininen | Chairman | 0 companies |
| Maj-Len Gunilla Eklund | Chairman | 0 companies |
| Markku Eero Antero Näreneva | Board of Directors | 0 companies |
| Stina Johanna Elisabeth Flood | Board of Directors | 0 companies |
| Karl Johan Anders Wickman | Board of Directors | 0 companies |
| Laila Jessica Bylund | Board of Directors | 0 companies |
| Aina Gunhild Virginia Arvidsson | Deputy Board Member | 0 companies |